Exelon Corporation (EXC) Earnings: A Dying Dividend Delivers Growth

Page 1 of 2

Exelon Corporation (NYSE:EXC) reported quarterly earnings yesterday, and the utility is making major moves. Although analysts’ earnings expectations were met, the company announced it will slash its 6.8% dividend next year by a whopping 40%. Is this the beginning of the end for this dividend stock, or a better strategy for long-term shareholder value? Let’s take a look at this quarter’s results, review some long-term trends, and see whether Exelon’s still got profits for your portfolio.

Number crunching
Exelon reported $6.44 billion in sales for Q4 2012, missing analyst expectations of $8.26 billion. Although it whiffed on its top line by 22%, the company squeaked by on net income. With $0.64 earnings per share, Mr. Market’s expectations were right on the money.

Exelon Corporation (NYSE:EXC)Comparing Exelon’s 2012 sales to previous years is tricky, since the company underwent a massive merger with Constellation Energy in March. However, operating EPS came in at $2.85 for 2012, 32% less than 2011′s $4.16.

Looking ahead, Exelon expects 2013 to continue the company’s downward trend, with EPS guidance in the $2.35-$2.65 range.

2012 in review
In the words of CEO and President Chris Cane: “2012 was a difficult year on the economic front for our sector.” To maintain its dividend, the utility cut $2.3 billion of growth investment plans, including nuclear upgrades and other investment targets.

Despite tight finances, the company managed to dole out its $2.10 annual dividend while completing its merger and reinvesting $5.9 billion in capital expenditures. A significant portion of its spending went toward renewables, with 400 MW wind and 330 MW solar added in 2012. Looking ahead, the company will continue clean energy investments (mainly solar), with additional focus on smart grid technology.

Source: Exelon Earnings Call Slides

But capital expenditures got their name for a reason – they use capital. In an effort to find financial stability, Exelon announced that, starting in Q2 2013, it would cut its dividend by 40% to $0.31 per share.

Speaking to shareholders, Cane explained:

We believe that our dividend should be sized to reflect our business model and keep our balance sheet strong. We also think that the dividend might be sized to allow us capacity and flexibility to pursue growth that will enhance the company’s long-term value. While we remain confident that there is $3 to $6 of megawatt hour of fundamental upside in the market, it is increasingly clear that we will not see the upside as soon as we had expected.

Page 1 of 2

Biotech Insider Alert - $6 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The Greatest Directors in the World

Largest Animals in the World

World’s Most Expensive Desserts

Best Selling Comic Books of All Time

A-list Actors who Sabotaged Their Career

Rappers With a College Degree

The Best Jazz Albums of all Time

The Most Influential Jazz Musicians

The World’s Most Famous Photographers

The Best Oscar-Winning Songs

Most Influential Choreographers Ever

Most Expensive Department Stores in the World

The Most Expensive Stolen Paintings in the World

The World’s Most Expensive Teas

Top Oscar Record Holders

The Most Expensive Flowers in the World

Countries With a Booming Film Industry

Most Expensive Cupcakes in the World

Uncommon European Escapes

The Most Stolen Artists in History

Best Travel Destinations in Australia

World’s Most Expensive Musical Instruments

World’s Most Famous Animals

Most Expensive Cakes in the World

Most Expensive Kosher Champagne in the World

Most Expensive Kosher Wine in the World

The Most Surprisingly Dark Fairy Tales

Most Popular Travel Destinations in Asia

The 10 Most Expensive Dresses Ever Worn to the Oscars

World’s Most Visited Art Museums

Best Countries for Photographers to Work in

Best Paid Jobs in the Film Industry

The Most Renowned Recovered Paintings Ever

Child Stars That Turned out Just Fine

Books That Were Banned in the Past Century

World’s Richest Dancers

Best Remedies against Bad Breath

Foods That Improve Your Skin Texture

Best-Selling Children’s Books of all Time

Foods That Boost Your Libido

Best-Selling Books of all Time

The Most Expensive Academy Awards Jewelry in History

Most Expensive Japanese Restaurant In New York City

The Best B-Boy Movies

Most Awesome Hip Hop Documentaries

Foods That Stain Your Teeth

Richest Doctors in the World

The Best Movie Sountracks Ever

The Highest Grossing Musicals on Broadway

The Most Successful Reality TV Stars

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!